22-23877795-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001024939.4(SLC2A11):āc.620C>Gā(p.Ala207Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,611,584 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001024939.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC2A11 | NM_001024939.4 | c.620C>G | p.Ala207Gly | missense_variant | 6/12 | ENST00000316185.9 | NP_001020110.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC2A11 | ENST00000316185.9 | c.620C>G | p.Ala207Gly | missense_variant | 6/12 | 1 | NM_001024939.4 | ENSP00000326748.8 | ||
ENSG00000251357 | ENST00000433835.3 | c.431+624C>G | intron_variant | 5 | ENSP00000400325.3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000409 AC: 1AN: 244552Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 132428
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1459400Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 725790
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2024 | The c.632C>G (p.A211G) alteration is located in exon 7 (coding exon 6) of the SLC2A11 gene. This alteration results from a C to G substitution at nucleotide position 632, causing the alanine (A) at amino acid position 211 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at